Abstract

Objective To investigate the clinical significance of tumor related gene gankyrin expression in pancreatic cancer. Methods The immunohistochemical staining was performed to study the gankyrin expression in 62 pairs of pancreatic cancer and matched non-tumor tissues. The correlations of gankyrin expression with pathological parameters and the influences on the prognosis were analyzed. Results Ggankyrin positivity in pancreatic cancer and matched non tumor tissue was 2.5%(45/62)and 19.4%(12/62), respectively. The positivity of gankyrin was significantly higher in pancreatic cancer compared with matched non-tumor tissues, and the differences were statistical significant (P 0.05). The 3-year survival rates of patients with positive and negative gankyrin expression were 17.8%(8/45)and 41.2%(7/17), respectively. Patients with positive gankyrin expression had a significantly shorter survival period compared with these with negative expression in pancreatic cancer tissues (P=0.034). Conclusions Gankyrin was overexpressed in pancreatic cancer, which was correlated with poor prognosis. Key words: Pancreatic neoplasms; Neoplasm staging; Neoplasm metastasis; Prognosis; Gankyrin

Talk to us

Join us for a 30 min session where you can share your feedback and ask us any queries you have

Schedule a call

Disclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.